Earnings History Data for 23andMe Holding Co. (ME) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

23andMe Holding Co.

23andMe Inc. is a consumer genetics and research company. It involved in discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory and cardiovascular diseases, in addition to other therapeutic areas. 23andMe Inc., formerly known as VG Acquisition Corp., is headquartered in Sunnyvale, CA.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
08-08-2024	AH		ME	23andMe Holding Co.	181.44	-0.14	0.00	-0.22	23andMe GAAP EPS of -$0.14, revenue of $40.42M misses by $11.63M [8/8/2024 4:32 PM]	0.3611	-0.01 (-3.16%)	0.38	0.01 (1.37%)	0.35 - 1.69	2,679,244	2,640,000	12,837
23andMe GAAP EPS of -$0.14, revenue of $40.42M misses by $11.63M [8/8/2024 4:32 PM]
23-05-2024	AH		ME	23andMe Holding Co.	255.95	-0.12	0.00	-0.14	23andMe GAAP EPS of -$0.43, revenue of $64.03M beats by $2.58M [5/23/2024 4:12 PM]	0.5174	0.01 (1.55%)	0.53	0.02 (3.83%)	0.35 - 2.15	6,521,694	3,780,000	104,758
23andMe, citing strategic alternatives review, not providing fiscal 2025 guidance [5/23/2024 4:42 PM] 23andMe GAAP EPS of -$0.43, revenue of $64.03M beats by $2.58M [5/23/2024 4:12 PM]
07-02-2024	AH		ME	23andMe Holding Co.	314.87	-0.17	0.00	-0.20	23andMe GAAP EPS of -$0.58, revenue of $44.7M misses by $11.6M [2/7/2024 4:48 PM]	0.6299	-0.09 (-13.08%)	0.67	-0.06 (-7.59%)	0.54 - 2.99	15,684,094	6,370,000	150,719
23andMe reportedly mulling split of company to maintain listing [2/7/2024 4:03 PM] 23andMe GAAP EPS of -$0.58, revenue of $44.7M misses by $11.6M [2/7/2024 4:48 PM] 23andMe stock falls 20% amid earnings report, breakup speculation [2/8/2024 1:15 PM]
08-11-2023	AH		ME	23andMe Holding Co.	419.52	-0.16	0.00	-0.15	23andMe GAAP EPS of -$0.16, revenue of $50M [11/8/2023 4:14 PM]	0.7102	-0.20 (-21.96%)	0.88	-0.03 (-3.31%)	0.61 - 3.50	5,161,418	4,150,000	36,603
23andMe GAAP EPS of -$0.16, revenue of $50M [11/8/2023 4:14 PM]
08-08-2023	AH		ME	23andMe Holding Co.	807.20	-0.22	0.00	-0.20	23andMe GAAP EPS of -$0.23 misses by $0.04, revenue of $60.86M beats by $3.96M [8/8/2023 4:18 PM]	1.52	-0.22 (-12.65%)	1.67	-0.07 (-4.02%)	1.51 - 6.31	4,513,697	2,000,000	37,493
23andMe GAAP EPS of -$0.23 misses by $0.04, revenue of $60.86M beats by $3.96M [8/8/2023 4:18 PM] 23andMe down 3% on Q1 earnings, guidance revision [8/8/2023 5:41 PM]
25-05-2023	AH	4:05 PM ET (May 25)	ME	23andMe Holding Co.	941.93	-0.14	0.00	-0.13	23andMe GAAP EPS of -$0.14 beats by $0.04, revenue of $92.4M beats by $4M [5/25/2023 4:08 PM]	2.10	0.06 (2.94%)	2.06	0.02 (0.98%)	1.74 - 6.31	3,761,742	3,020,000	26,411
23andMe GAAP EPS of -$0.14 beats by $0.04, revenue of $92.4M beats by $4M [5/25/2023 4:08 PM] 23 and Me fiscal 2024 revenue outlook misses consensus [5/25/2023 5:27 PM]
08-02-2023	AH	4:05 PM ET (Feb 8)	ME	23andMe Holding Co.	1,230	-0.20	0.00	-0.21	23andMe GAAP EPS of -$0.20 beats by $0.01, revenue of $67M beats by $1.11M [2/8/2023 4:10 PM]	2.72	0.20 (7.94%)	2.78	0.26 (10.32%)	2.02 - 6.31	7,043,260	2,040,000	67,184
23andMe GAAP EPS of -$0.20 beats by $0.01, revenue of $67M beats by $1.11M [2/8/2023 4:10 PM] 23andMe up 12% on 2023 outlook raise, quarterly beats [2/8/2023 4:48 PM]
07-11-2022	AH	4:05 PM ET (Nov 7)	ME	23andMe Holding Co.	1,350	-0.15	0.00	-0.04	23andMe GAAP EPS of -$0.15, revenue of $75.66M [11/7/2022 4:12 PM]	2.94	0.01 (0.51%)	3.02	0.09 (3.07%)	2.12 - 13.68	3,246,125	2,500,000	32,069
23andMe GAAP EPS of -$0.15, revenue of $75.66M [11/7/2022 4:12 PM] 23andMe Reports FY2023 Second Quarter Financial Results [Nov-07-22 04:01PM] 23andMe Trials-in-Progress Poster Details Expansion Cohorts for 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancers (SITC) 2022 Annual Meeting [Nov-07-22 08:00AM]
08-08-2022	AH	4:05 PM ET (Aug 8)	ME	23andMe Holding Co.	1,280	-0.20	0.00	-0.25	23andMe GAAP EPS of -$0.20, revenue of $64.5M [8/8/2022 4:13 PM]	3.73	-0.25 (-6.28%)	3.33	-0.65 (-16.33%)	2.12 - 13.68	7,885,747	3,440,000	394,430
23andMe GAAP EPS of -$0.20, revenue of $64.5M [8/8/2022 4:13 PM] 23andMe stock slumps 14% as Q1 net loss widens on higher operating expenses [8/9/2022 9:17 AM] 23andMe Reports FY2023 First Quarter Financial Results [Aug-08-22 04:05PM] Why 23andMe Stock Jumped Higher on Monday [Aug-08-22 01:31PM]
26-05-2022	AH	4:05 PM ET (May 26)	ME	23andMe Holding Co.	1,250	-0.13	0.00	0.00	23andMe GAAP EPS of -$0.16 misses by $0.01, revenue of $100.56M misses by $2.23M [5/26/2022 4:12 PM]	2.87	-0.02 (-0.87%)	2.72	-0.17 (-5.88%)	2.15 - 13.68	8,783,689	2,700,000	162,284
23andMe GAAP EPS of -$0.16 misses by $0.01, revenue of $100.56M misses by $2.23M [5/26/2022 4:12 PM] 10 Stocks To Sell Now According To David Einhorns Greenlight Capital [May-26-22 11:13AM] 23andMe Reports FY2022 Fourth Quarter and Full Year Financial Results [May-26-22 04:05PM] 23andMe stock falls on widening loss [May-26-22 06:51PM] Why 23andMe Stock Was Lagging the Market Today [May-27-22 02:28PM]
10-02-2022	AH	4:05 PM ET (Feb 10)	ME	23andMe Holding Co.	2,250	-0.21	0.00	0.00	23andMe GAAP EPS of -$0.21 misses by $0.06, revenue of $56.89M beats by $2.59M [2/10/2022 4:16 PM]	4.51	-0.45 (-9.15%)	4.69	-0.28 (-5.63%)	3.96 - 15.16	4,633,987	2,770,000	45,315
23andMe GAAP EPS of -$0.21 misses by $0.06, revenue of $56.89M beats by $2.59M [2/10/2022 4:16 PM] 23andMe falls 3% after-hours following quarterly bottom line miss [2/10/2022 6:14 PM] 23andMe Reports FY2022 Third Quarter Financial Results [Feb-10-22 04:04PM]
10-11-2021	AH	9:25 AM ET (Nov 10)	ME	23andMe Holding Co.	5,790	-0.04	0.00	0.00	23andMe EPS beats by $0.07, misses on revenue [11/10/2021 4:12 PM]	13.03	1.51 (13.11%)	12.01	0.49 (4.25%)	7.01 - 18.16	4,430,486	2,800,000	59,942
23andMe EPS beats by $0.07, misses on revenue [11/10/2021 4:12 PM] 23andMe to Present at Upcoming Virtual Healthcare Conferences [Nov-09-21 04:30PM] What Happens to All Those Covid Test Sites After the Pandemic [Nov-09-21 12:04PM] 23andMe Announces Appointment of Dr. Sandra Hernández to Board of Directors [Nov-09-21 09:00AM] 23andMe Reports FY2022 Second Quarter Financial Results [Nov-10-21 04:05PM] 23andMe Stock Jumps as Quarterly Loss Narrows, Revenue Rises [Nov-11-21 04:50AM] Why 23andMe Stock Scored an 11% Gain Today [Nov-11-21 01:22PM]
13-08-2021	PM	9:25 AM ET (Aug 13)	ME	23andMe Holding Co.	3,330	-0.25	0.00	0.00	23andMe reports FQ1 results; issues full year guidance [8/13/2021 7:15 AM]	7.59	-0.34 (-4.29%)	8.00	0.07 (0.88%)	7.32 - 18.16	3,719,990	1,590,000	62,765
23andMe reports FQ1 results; issues full year guidance [8/13/2021 7:15 AM] 23andMe Reports FY2022 First Quarter Financial Results [Aug-13-21 07:00AM] Consumer genetics company 23andMe loss widens in first earnings report since going public [Aug-13-21 07:23AM] Wish stock tanks, SoFi profit outlook disappoints, Honest misses on revenue [Aug-13-21 09:54AM]